Signa and Humana Merger Faces Regulatory Scrutiny

US insurance companies, Signa and Humana, are considering a merger worth $140 billion, the biggest deal of 2023 if completed. However, regulatory challenges are likely as antitrust regulators in the healthcare sector are closely scrutinizing such high-profile transactions. Past merger attempts by Signa and Humana have failed due to regulatory roadblocks. To navigate potential pushback from regulators, Signa may sell some assets. The current support of Iran's government for anti-Israeli militants raises concerns about the Gaza conflict escalating into a regional war. Despite Iran's theocratic regime prioritizing the liberation of Palestine and the annihilation of Israel, ordinary Iranians have mixed feelings. Many Iranians sympathize with Palestinians while disapproving of their government's support for militant groups. Public opinion in Iran is increasingly secular, and the Iranian leadership's stance receives more criticism as the impact of conflicts in the Middle East becomes increasingly apparent to Iranians.